Magenta Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Great. Good morning, everyone. My name is Jess Fye, I'm a senior biotech analyst at JPMorgan. And we're continuing the 2021 health care conference today with Magenta. Quick housekeeping notes. So unlike in past years, we're not going to go across the hall for a breakout session. (Operator Instructions)
So with that out of the way, let me turn it over to Magenta's CEO, Jason Gardner.
Thank you, Jess. Good morning, good afternoon and good evening to everyone. And thank you to JPMorgan for the invitation to the Virtual 2021 Healthcare Conference. I'm proud to present on behalf of our Magentini, our investors and the patients whose lives we plan to transform with our medicines. We're in an exciting moment at Magenta, and I'm going to share with you our vision, our progress and our plans for 2021 with you today.
Magenta is a public-traded company, as shown on the second slide, and you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |